by Editorial | May 7, 2020 | 2020 News, San Diego Times
San Diego-based Genalyte announced Thursday its SARS-CoV-2 Multi-Antigen Serology Panel, which tests for antibodies the body produces in response to the novel coronavirus, is available to the public in partnership with San Diego Blood Bank. A reliable antibody test...
by Jonathan Wosen | May 7, 2020 | 2020 News, San Diego Union Tribune
The joint effort will identify COVID-19 survivors whose antibodies may treat the disease in others. A partnership announced Thursday between the San Diego Blood Bank and Genalyte, a local healthcare diagnostics company, will enable thousands of San Diegans to get...
by Editorial | May 7, 2020 | 2020 News
Appointments Available at Blood Bank and Additional Drive-Thru Location San Diego, May 7, 2020 — Genalyte, the company empowering physicians and patients with real-time diagnostics and healthcare analytics, today announced its SARS-CoV-2 Multi-Antigen Serology Panel,...
by Editorial | Apr 29, 2020 | 2020 News, World Pharma Today
Genalyte’s U.S. Food and Drug Administration (FDA)-cleared Maverick™ Diagnostic System will expand antibody testing in the fight against COVID-19 with the launch of its SARS-CoV-2 Multi-Antigen Serology Panel. The antibody test and results represent a crucial step in...
by Editorial | Apr 29, 2020 | 2020 News, iMicroNews
First instrument-based, rapid test uses multi-antigen approach to achieve best-in-class sensitivity and specificity, U.S. FDA EUA submitted. Genalyte, the company empowering physicians and patients with real-time diagnostics and healthcare analytics, announced today...
by Chloe Kent | Apr 28, 2020 | 2020 News, Medical Device Network
Genalyte has announced that its rapid Covid-19 serology panel is available on its Maverick platform. The SARS-CoV-2 Multi-Antigen Serology Panel detects the presence of IgG and IgM antibodies, which are produced in bodies when infected by the SARS-CoV-2 virus that...
Recent Comments